Dyne Therapeutics

DYN

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-343.89M

EBITDA$-315.18M

EBIT$-317.42M

Pre-tax Income$-446.21M

Net Income$-317.42M

Cash Equivalent$463.89M

Total Debt$25.3M

Book Value$647.16M

Book Value Per Share6.97

Return on Equity (ROE)-50.40%

Return on Assets (ROA)-45.92%

Return on Invested Capital (ROI)-50.40%

Net Profit Marginundefined

Current Ratio15.60

Quick Ratio15.20

Long-Term Debt / Equity0.00